Emerging evidence has indicated that long non-coding RNA plays an important role in carcinogenesis at the transcriptional and post-translational levels. The regulation of carcinogenesis-related effectors is potent in the determination of tumor initiation and progression. In the current study, FOXD2-AS1 was found to interact with microRNA (miR)-185-5p to modulate proliferation, migration, and invasion of colorectal cancer (CRC) cells. Interestingly, expression of cell division control 42 was significantly influenced by FOXD2-AS1 and miR-185-5p. In CRC patients, the expression level of FOXD2-AS1 in CRC tissue was closely associated with miR-185-5p and cell division control 42, and implicated in the overall survival rate. Therefore, our study suggests that long non-coding RNA FOXD2-AS1 plays a positive role in CRC and could be developed and used as a potential biomarker for the diagnosis and therapy of CRC. This will greatly improve the prevention and treatment of the third most common cancer worldwide.
| INTRODUCTION
Colorectal cancer (CRC) is one of the most common cancers worldwide, with high incidence and mortality. 1 Although the incidence rate is higher in developed countries, the overall mortality is higher in developing countries. 2 Colorectal cancer begins with polyps, which subsequently become adenomas with high-grade dysplasia, and ultimately to colonic carcinoma. Current investigations of the pathogenesis of CRC have indicated that genetic and epigenetic changes significantly contribute to CRC. 3, 4 Sequential genetic and epigenetic abnormal alterations in specific oncogenes and/or tumor suppressors result in CRC onset, progression, and metastasis. 5 Although immune activation and intestinal bacterial dysbiosis are also implicated in CRC genesis, 3, 6, 7 molecular characterizations are necessary to understand the precise cascade of events for diagnostic and therapeutic purposes.
Long non-coding RNA (lncRNA) is functionally defined as nonprotein coding transcripts >200 nt in length. 8 These so-called junk lncRNAs have been found to be critical players in the regulation of cancer phenotype through their interactions with DNA, RNA, and proteins. 9 Many lncRNA are uniquely expressed in differentiated tissue and specific cancers, 9 indicating that lncRNA could be potential treatment targets with high specificity. Recent studies have investigated the role of lncRNA FOXD2-AS1 in the regulation of a variety of carcinoma development, including CRC. [10] [11] [12] [13] Overexpression of FOXD2-AS1 promotes non-small-cell lung cancer growth. 12 In certain human CRC cell lines, FOXD2-AS1 is upregulated and associated with cell proliferation and invasion. 10 Therefore, an understanding of the mechanisms associated with FOXD2-AS1 in carcinogenesis could be potentially beneficial to CRC therapy.
In the current study, we tested the expression levels of FOXD2- 
AS1 in human CRC tissues and a number of human CRC cell lines ---------------------------
-------------------------------------------------------------------------------------------------------------------------------------------
| Cell proliferation assay
Cells in 24-well plates with different treatments were subjected to medium replacement with 10 lL sterile MTT dye (5 mg/mL). After incubation at 37°C for 4 hours, the MTT solution was removed and 150 lL DMSO was added to each well. Absorbance was read at 490 nm on an enzyme immunoassay analyzer (Biotek, Winooski, VT, USA).
| Wound healing assay
When cells grew to approximately 70%-80% confluence in culture wells, a 1-mL pipette tip was used to gently scratch the monolayer across the center of the well. Wells were briefly washed twice with medium to remove the detached cells. Fresh medium was added and cells grew for an additional 24 hours before photographs were taken on a microscope.
| Crystal violet staining
Cells subjected to crystal violet staining were washed with cold PBS, and fixed with ice-cold methanol for 10 minutes. Then cells were stained with 0.5% crystal violet solution in 25% methanol for 10 minutes. Cells were washed with water several times prior to observation under a microscope.
| Transwell assay
Cell migration assays were carried out using 24-well Transwell chambers (8-lm pore size; BD Biosciences). Approximately 1 9 10 5 cells were resuspended in 100 lL serum-free medium and added into the top chambers, which had been coated with Matrigel matrix (Corning, Corning, NY, USA), and DMEM containing 10% FBS was filled into the bottom chambers. After 24 hours of incubation at 37°C, the cells that did not migrate through the pores were removed by a cottontipped applicator, and cells on the lower surface of the membrane were subjected to crystal violet staining.
| Constructions and luciferase assay
The 3 
| Western blot analysis
Total protein was isolated by RIPA buffer in the presence of proteinase inhibitors, and quantified by Bradford assay (Sigma). Total protein (20 lg) was loaded into each well and transferred to PVDF membranes. Primary antibody used against human cell division control 42 (CDC42) (Cambridge, UK) was diluted 1:2000 and incubated with the membranes at 4°C overnight. Secondary anti-rabbit antibody (Cambridge, UK) was diluted 1:5000 and incubated with the membranes at room temperature for 1 hour.
| Statistical analyses
Prism 6 (GraphPad) was used to carry out statistical analyses.
Unpaired t-test, one-way ANOVA, two-way ANOVA, and the chisquare-test were used as indicated. Finally, Transwell assay was used to measure the cell capability of motility and invasion. Consistent with proliferation and migration assays, we found that overexpression of FOXD2-AS1 in HCT-116 and SW620
| RESULTS

| Expression of FOXD2-AS1 is increased in colonic cancer cells
promoted motility and invasion, whereas suppression of FOXD2-AS1 expression led to diminished motility and invasion ( Figure 2D ). To eliminate the off-target possibility of siRNA knockdown, an alternative set of siRNA targeting FOXD2-AS1 was used. We observed comparable effects of both siRNAs on HT-29 and LOVO proliferation ( Figure S2 ).
| FOXD2-AS1 interacts with miR-185-5p and regulates its expression
To investigate the role of FOXD2-AS1 in colonic carcinogenesis, the Starbase database was utilized to predict the interactions between FOXD2-AS1 and potential miRNA. 14, 15 Human miR-185-5p (hsa-miR-185-5p) was proposed to be a potential binding candidate of interest ( Figure 3A ). To test this binding in vivo, 3 0 -end biotinylated miR-185-5p, miR-150-5p, and miR-4306 were separately synthesized and transfected into LOVO cells. 16 After streptavidin capture, the input and bound fractions were tested by qRT-PCR targeting FOXD2-AS1. In F I G U R E 3 FOXD2-AS1 interacts with microRNA (miR)-185-5p in colorectal cancer cells. A, Predicted interaction between human miR-185-5p and FOXD2-AS1 in Starbase. B, Synthetic biotin-labeled microRNAs were transfected into HCT116 and SW620 cells and mRNA levels of FOXD2-AS1 were tested by quantitative RT-PCR in precipitates pulled down by streptavidin (B). **P < .01, two-way ANOVA test contrast to miR-150-5p and miR-4306, significant association between FOXD2-AS1 and miR-185-5p was determined ( Figure 3B ).
| FOXD2-AS1 regulates CDC42 expression at transcriptional and protein levels
To investigate the effects of this association, overexpression of | 2239 CDC42 at RNA and protein levels ( Figure 4D,E) . Next, luciferase assay was used in the aforementioned four cell lines transfected with pGL3 harboring the CDC42 3 0 -UTR region, a region that showed direct regulatory effects on CDC42 expression. Positive regulation of CDC42 3 0 -UTR activity by FOXD2-AS1 was determined by either overexpressing ( Figure 4F ) or knocking down ( Figure 4G ) FOXD2-AS1 in the colon cancer cell lines. In addition, we used an alternative set of siRNA targeting FOXD2-AS1 to exclude the possibility of off-target effects of the original FOXD2-AS1 siRNA set ( Figure S3 ).
| FOXD2-AS1 promotes proliferation, migration, and invasion in a miR-185-5p-dependent manner
As FOXD2-AS1 is associated with miR-185-5p and regulates its expression, we undertook a rescue experiment wherein SW620 cells overexpressing FOXD2-AS1 were transfected transfected with either control miRNA duplexes or miR-185-5p duplexes. The MTT assay showed that miR-185-5p expression partially suppressed FOXD2-AS1-induced cell proliferation ( Figure 5A ). In addition, cell proliferation evaluated by crystal violet staining consistently illustrated that the colony number formed in cells overexpressing FOXD2-AS1 and transfected with miR-185-5p
was less than those overexpressing FOXD2-AS1 only ( Figure 5B ). In the wound healing assay, transfection with miR-186-5p facilitated wound closure in the cells overexpressing FOXD2-AS1, compared with the FOXD2-AS1 + NC group ( Figure 5C ). Finally, reduction in cell motility and invasion was observed in the FOXD2-AS1 + miR-185-5p group compared with the FOXD2-AS1 + NC group in the Transwell assay (Figure 5D ). overexpression at protein (E) and mRNA (F) levels. *P < .05, two-way ANOVA test; **P < .01, one-way ANOVA test levels of FOXD2-AS1 are positively related to a lower 6-year, but not 12-year, post-surgery survival rate ( Figure 6C ).
|
| DISCUSSION
Epigenetic alterations in human CRC have been recognized and investigated for a long time. 5 Abnormalities in epigenetics, including DNA methylation, histone acetylation, and methylation, chromatin remodeling and non-coding RNAs, have been reported in every aspect of tumor development. 18 Genomic mutations and/or aberrant expression of certain regions within the genome do not necessarily encode proteins. 19 However, lncRNAs are usually the transcribed products of these regions. 19 Long non-coding RNAs play a critical role in gene regulation, and thereafter has impacts on protein synthesis and multiple aspects of cellular homeostasis. 20 By using nextgeneration sequencing methods, a great number of lncRNAs have been determined to be associated with different cancer types.
19
In our study, we focused on lncRNA FOXD2-AS1, which has been found to be aberrantly expressed in lung and CRC cancers. Next, we investigated the downstream molecular mechanism of FOXD2-AS1 in CRC. MicroRNA-185-5p was predicted to be a molecule that can directly interact with FOXD2-AS1 ( Figure 3A ). In the following biotin-streptavidin pull-down assay, miR-185-5p, but not miR-150-5p or miR-4306, was found to be associated with FOXD2-AS1 ( Figure 3B ). Therefore, FOXD2-AS1 and miR-185-5p are associated with each other in a complex, if not direct, interaction. Previous studies have reported that lncRNA-miRNA interaction is highly involved in the regulation of gene expression. 21 Long non-coding RNA might function as endogenous sponges to absorb miRNA, which subsequently reduces the level of free miRNA and regulates gene expression. 22, 23 We found that the miRNA-185-5p expression In human CRC tumors, FOXD2-AS1 was significantly correlated with CDC42 and miR-185-5p ( Figure 6A,B) . Strikingly, FOXD2-AS1 levels are closely associated with 6-year survival rates in CRC patients ( Figure 6C ). As CRC usually develops from early-stage benign precancerous polyps to late-stage metastatic disease, the discovered association between FOXD2-AS1 and CRC survival could potentially be used as an early biomarker of CRC; patients with high expression levels of FOXD2-AS1 in colon tissue should be cautioned and subjected to further screening or diagnoses procedures.
A previous study found the FOXD2-AS1 is involved in the regulation of N-and E-cadherin expression, 10 two important proteins in epithelial-mesenchymal transition in CRC. During epithelial-mesenchymal transition, CDC42 plays a regulatory role in actin rearrangement and assembly, including the formation of lamellipodia and filopodia. 24 Hence, it is hypothesized that FOXD2-AS1 interacts with miR-185-5p
to regulate the expression of CDC42, which may be responsible for the alterations in N-and E-cadherin. 25 This needs to be tested further.
In summary, we found that FOXD2-AS1 plays a negative role in CRC carcinogenesis through its interplay with miR-185-5p and CDC42. The expression of FOXD2-AS1 is significantly associated with miR-185-5p and CDC42, and implicated in the survival of patients with CRC.
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